top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Improvement in glycaemic control is no longer an acceptable surrogate for efficacy (or safety) with regard to cardiovascular outcomes.35 Safety must be formally demonstrated in adequately powered ...

European Heart Journal, Zannad, Faiez, Stough, Wendy Gattis, Pocock, Stuart J., Sleight, Peter, Cushman, William C, Cleland, John G.F., McMurray, John J.V., Lonn, Eva, Geller, Nancy L., Wedel, Hans, ...

Date : 01/05/2012 Item size : 369253 bytes
Ehjournal

[...]at approval, the relation between non-cardiovascular benefit and cardiovascular risk may not be adequately defined. Deficiencies of pre-approval data are exemplified by issues emerging from the ...

European Heart Journal, Borer, Jeffrey S., Pouleur, Hubert, Abadie, Eric, Follath, Ferrenc, Wittes, Janet, Pfeffer, Marc A., Pitt, Bertram, Zannad, Faiez

Date : 01/08/2007 Item size : 216749 bytes
Ehjournal

Improvement in glycaemic control is no longer an acceptable surrogate for efficacy (or safety) with regard to cardiovascular outcomes.35 Safety must be formally demonstrated in adequately powered ...

European Heart Journal, Zannad, Faiez, Stough, Wendy Gattis, Pocock, Stuart J., Sleight, Peter, Cushman, William C, Cleland, John G.F., McMurray, John J.V., Lonn, Eva, Geller, Nancy L., Wedel, Hans, ...

Date : 01/05/2012
Ehjournal

[...]at approval, the relation between non-cardiovascular benefit and cardiovascular risk may not be adequately defined. Deficiencies of pre-approval data are exemplified by issues emerging from the ...

European Heart Journal, Borer, Jeffrey S., Pouleur, Hubert, Abadie, Eric, Follath, Ferrenc, Wittes, Janet, Pfeffer, Marc A., Pitt, Bertram, Zannad, Faiez

Date : 01/08/2007